Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 12, Number 4—April 2006

Dispatch

Immune Restoration Disease in HIV Patient

Neil E. Jenkins*Comments to Author , Mike B.J. Beadsworth*, James J. Anson*, Fred J. Nye*, Vanessa J. Martlew*, and Nick J. Beeching*
Author affiliations: *Liverpool School of Tropical Medicine, Liverpool, United Kingdom

Main Article

Figure 1

Chest radiographs at initiation of A) highly active antiretroviral therapy (HAART) showing left hilar mass; and B) after 9 weeks of HAART and antituberculosis treatment, suggesting enlargement of the hilar mass consistent with immune restoration disease. (The radiograph has been flipped horizontally to aid comparison).

Figure 1. Chest radiographs at initiation of A) highly active antiretroviral therapy (HAART) showing left hilar mass; and B) after 9 weeks of HAART and antituberculosis treatment, suggesting enlargement of the hilar mass consistent with immune restoration disease. (The radiograph has been flipped horizontally to aid comparison).

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO